
Temsujohn 0.4mg Tablet ER
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Tamsulosin (0.4mg)
Overview Temsujohn 0.4mg Tablet ER
Alfuzosin extended-release 0.4mg tablets are alpha-blockers prescribed for benign prostatic hyperplasia (BPH). They ease urinary symptoms such as hesitancy, but don't shrink the prostate. Always follow your doctor's instructions regarding dosage and duration. This medication can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms, so complete the prescribed course. Common side effects include lightheadedness, back discomfort, chest pain, ejaculatory dysfunction, and retrograde ejaculation. Report any persistent or bothersome side effects to your physician immediately. Lifestyle adjustments can aid symptom management: void as soon as you feel the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeinated or alcoholic beverages. Inform your doctor about all other medications before starting this treatment. If undergoing cataract or glaucoma surgery, notify your ophthalmologist about your alfuzosin use. Individuals with liver impairment require careful monitoring and regular checkups.
Uses of Temsujohn 0.4mg Tablet ER
Managing benign prostatic enlargement
Major Benefits of Temsujohn 0.4mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.4mg Extended-Release Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Temsujohn 0.4mg Tablet ER:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Temsujohn 0.4mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Temsujohn 0.4mg Extended-Release Tablet can be consumed with or without food, although consistent timing is recommended.
How Temsujohn 0.4mg Tablet ER works:
Temsujohn 0.4mg Extended-Release tablets are alpha-adrenergic receptor antagonists. Their mechanism of action involves relaxing the bladder neck and prostate muscles, thereby facilitating easier urinary flow. This improves bladder emptying and lessens urinary frequency and urgency associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Temsujohn 0.4mg extended-release tablets and alcohol can result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Temsujohn 0.4mg Extended-Release Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Temsujohn 0.4mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.
DrivingSAFE
Driving ability is typically unaffected by Temsujohn 0.4mg Extended-Release tablets.
KidneySAFE IF PRESCRIBED
Temsujohn 0.4mg Extended-Release tablets are considered safe for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Temsujohn 0.4mg extended-release tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Temsujohn 0.4mg Tablet ER :
Should you forget a Temsujohn 0.4mg Extended-Release Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Temsujohn 0.4mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Sulfonylamide |
| Developing Habits | No. |
| Treatment Category | Urological Care |
